Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,957 public trials 633 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

NCT04200963

Conditions
Advanced Cancer, Advanced Solid Tumor, Bladder Cancer, +35 more
Locations
  • Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Johns Hopkins Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

A Study of hSTC810 With Advanced/Metastatic Solid Tumors (STCUBE-001)

NCT05231746

Conditions
Adnexal Diseases, Advanced Solid Tumor, Colonic Diseases, +33 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Mount Sinai Hospital New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Korea University Anam Hospital Seoul, South Korea
View Trial Details
Completed

A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)

NCT04834778

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +36 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • HealthPartners Cancer Care Center Saint Paul, Minnesota, United States
  • Baylor University Medical Center Dallas, Texas, United States
  • The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

NCT04540705

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Local Institution - 0005 Springdale, Arkansas, United States
  • Local Institution Louisville, Kentucky, United States
  • Local Institution - 0001 St Louis, Missouri, United States
  • Local Institution - 0009 New York, United States
View all 39 locations
View Trial Details

Related conditions